The Investigator-Initiated Research Award is intended to support studies that have the potential to make an important contribution to reconstructive transplant research, patient care and/or quality of life. Though the RTRP Investigator-Initiated Research Award supports groundbreaking research, all projects must demonstrate solid scientific rationale with military-relevant utility. Investigator-Initiated Research Award applications may focus on any… Read more »
The Investigator-Initiated Research Award is intended to support studies that have the potential to make an important contribution to reconstructive transplant research, patient care and/or quality of life. Though the RTRP Investigator-Initiated Research Award supports groundbreaking research, all projects must demonstrate solid scientific rationale with military-relevant utility. Investigator-Initiated Research Award applications may focus on any… Read more »
The RTRP Concept Award, released in June 2026, has been revised to extend the pre-application deadline to October 21, 2026, and the application submission deadline to November 4, 2026. The Reconstructive Transplant Research (RTR) Program was initiated in 2012 to advance the science and execution of complex hand, face and other vascularized composite allotransplantation (VCA)… Read more »
The RTRP Concept Award, released in June 2026, has been revised to extend the pre-application deadline to October 21, 2026, and the application submission deadline to November 4, 2026. The Reconstructive Transplant Research (RTR) Program was initiated in 2012 to advance the science and execution of complex hand, face and other vascularized composite allotransplantation (VCA)… Read more »
Concept Award The FY26 RCRP CA supports highly innovative, untested, potentially groundbreaking novel concepts in rare cancers. The CA is not intended to support an incremental progression of an already established research project. Instead, this award mechanism allows PIs the opportunity to pursue serendipitous observations. Presentation of preliminary data is not consistent with the intent… Read more »
Concept Award The FY26 RCRP CA supports highly innovative, untested, potentially groundbreaking novel concepts in rare cancers. The CA is not intended to support an incremental progression of an already established research project. Instead, this award mechanism allows PIs the opportunity to pursue serendipitous observations. Presentation of preliminary data is not consistent with the intent… Read more »
Idea Development Award The FY26 RCRP IDA promotes ideas that are ready for development and have the potential to yield high-impact findings and new avenues of investigation. This award supports research supported by preliminary data that could lead to critical discoveries or major advancements that will accelerate progress toward eradicating rare cancers. Resource and Community… Read more »
Idea Development Award The FY26 RCRP IDA promotes ideas that are ready for development and have the potential to yield high-impact findings and new avenues of investigation. This award supports research supported by preliminary data that could lead to critical discoveries or major advancements that will accelerate progress toward eradicating rare cancers. Resource and Community… Read more »
The large majority of the injuries sustained by military personnel in U.S. combat efforts involve soft tissue wounds and skeletal fractures. Orthopaedic injuries sustained during combat-related activities tend to be heterogeneous and complex in nature, typically involving multiple limb trauma, open fractures, major tissue loss, and a high degree of wound contamination. These injuries may… Read more »
The large majority of the injuries sustained by military personnel in U.S. combat efforts involve soft tissue wounds and skeletal fractures. Orthopaedic injuries sustained during combat-related activities tend to be heterogeneous and complex in nature, typically involving multiple limb trauma, open fractures, major tissue loss, and a high degree of wound contamination. These injuries may… Read more »
The FY26 KCRP Concept Award supports highly innovative, untested, potentially groundbreaking novel concepts in kidney cancer that address at least one of the FY26 KCRP Focus Areas. The Concept Award is not intended to support incremental progression of an established research project; instead, it allows PIs to pursue serendipitous observations. Preliminary data are not allowed… Read more »
Concept Award The FY26 KCRP Concept Award supports highly innovative, untested, potentially groundbreaking novel concepts in kidney cancer that address at least one of the FY26 KCRP Focus Areas. The Concept Award is not intended to support incremental progression of an established research project; instead, it allows PIs to pursue serendipitous observations. Preliminary data are… Read more »
Academy of Kidney Cancer Investigators – Early-Career Scholar Award The intent of the FY26 KCRP AKCI-ECSA mechanism is to solicit applications for Scholars to join the existing AKCI. This award mechanism enables the ECS (the investigator named as the PI on the application) to pursue a kidney cancer project with the guidance of the Designated… Read more »
Academy of Kidney Cancer Investigators – Early-Career Scholar Award The intent of the FY26 KCRP AKCI-ECSA mechanism is to solicit applications for Scholars to join the existing AKCI. This award mechanism enables the ECS (the investigator named as the PI on the application) to pursue a kidney cancer project with the guidance of the Designated… Read more »
Resource Development Award The BMFRP RDA supports the development of a multiomic atlas generated from well-annotated human BMF samples, with omic data derived from marrow specimens. The resulting dataset should serve as an open-access, durable resource to be shared with the BMF research and clinical communities and is expected to facilitate further key discoveries that… Read more »
Resource Development Award The BMFRP RDA supports the development of a multiomic atlas generated from well-annotated human BMF samples, with omic data derived from marrow specimens. The resulting dataset should serve as an open-access, durable resource to be shared with the BMF research and clinical communities and is expected to facilitate further key discoveries that… Read more »
Idea Development Award The BMFRP Idea Development Award (IDA) is intended to support innovative ideas and high-impact approaches based on scientifically sound evidence to move toward the BMFRP’s vision of understanding and curing BMF diseases. The proposed research should include a well-formulated, testable hypothesis based on strong scientific rationale and a well-developed and articulated research… Read more »
Idea Development Award The BMFRP Idea Development Award (IDA) is intended to support innovative ideas and high-impact approaches based on scientifically sound evidence to move toward the BMFRP’s vision of understanding and curing BMF diseases. The proposed research should include a well-formulated, testable hypothesis based on strong scientific rationale and a well-developed and articulated research… Read more »
The CDMRP’s CRRP focuses on research relating to forward-deployable solutions that can promptly address life threatening injuries and medical diagnostics, threats, and treatments, and medical threats and treatments for Service members in battlefield settings. Translational Research Award The FY26 CRRP TRA intends to support mature high-impact translational research that will accelerate innovative ideas into clinical… Read more »
The CDMRP’s CRRP focuses on research relating to foward-deployable solutions that can promptly address life threatening injuries and medical diagnostics, threats, and treatments, and medical threats and treatments for Service members in battlefield settings. Translational Research Award The FY26 CRRP TRA intends to support mature high-impact translational research that will accelerate innovative ideas into clinical… Read more »
Parkinson’s disease (PD) is a degenerative movement disorder of the central nervous system resulting from a loss of neurons in a region of the brain called the substantia nigra. These neurons produce dopamine, a neurotransmitter important for motor control; however, as PD progresses, the death of dopaminergic neurons results in reduced dopamine levels and impairment… Read more »
Parkinson’s disease (PD) is a degenerative movement disorder of the central nervous system resulting from a loss of neurons in a region of the brain called the substantia nigra. These neurons produce dopamine, a neurotransmitter important for motor control; however, as PD progresses, the death of dopaminergic neurons results in reduced dopamine levels and impairment… Read more »
Duchenne muscular dystrophy (DMD) results from mutations in the dystrophin gene that lead to an absence of dystrophin in muscle cells, allowing these cells to be easily damaged. Boys living with DMD experience devastating muscle weakness that affects the skeletal muscles, heart, and respiratory muscles. Currently, there is no cure for DMD and young men… Read more »
Duchenne muscular dystrophy (DMD) results from mutations in the dystrophin gene that lead to an absence of dystrophin in muscle cells, allowing these cells to be easily damaged. Boys living with DMD experience devastating muscle weakness that affects the skeletal muscles, heart, and respiratory muscles. Currently, there is no cure for DMD and young men… Read more »
Neurofibromatosis Research Academy – Leadership Award The FY26 NFRALA mechanism is soliciting applications for a Director and Deputy Director to stand up and lead the Neurofibromatosis Research Academy (NFRA). The Academy Director and Deputy Director (referred to as Academy Leadership) must be established NF researchers and should be at different institutions. The Academy Leadership must… Read more »
Neurofibromatosis Research Academy – Leadership Award The FY26 NFRALA mechanism is soliciting applications for a Director and Deputy Director to stand up and lead the Neurofibromatosis Research Academy (NFRA). The Academy Director and Deputy Director (referred to as Academy Leadership) must be established NF researchers and should be at different institutions. The Academy Leadership must… Read more »
Neurofibromatosis (NF) is a group of three genetically distinct disorders that cause tumors to grow in the nervous system. It also produces other abnormalities in the skin and bones. Exploration-Hypothesis Development Award The NFRP EHDA supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in NF research. Studies should lay the groundwork… Read more »
Neurofibromatosis (NF) is a group of three genetically distinct disorders that cause tumors to grow in the nervous system. It also produces other abnormalities in the skin and bones. Exploration-Hypothesis Development Award The NFRP EHDA supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in NF research. Studies should lay the groundwork… Read more »
The Traumatic Brain Injury and Psychological Health Research Program (TBIPHRP) released program announcements for the following funding opportunities: Health Services Research Award – Pre-Application Due: September 24, 2026 Maturing research ideas into clinical practice and patient benefit is at the heart of all CDMRP research programs. Despite significant investment, the gap between what is possible… Read more »
The Traumatic Brain Injury and Psychological Health Research Program (TBIPHRP) released program announcements for the following funding opportunities: Clinical Trial Award – Pre-Application Due: July 13, 2026 The TBIPHRP Clinical Trial Award mechanism supports the rapid execution of clinical trials with the potential to have a significant impact on the treatment or management of psychological… Read more »
The Traumatic Brain Injury and Psychological Health Research Program (TBIPHRP) released program announcements for the following funding opportunities: Clinical Trial Award – Pre-Application Due: July 13, 2026 The TBIPHRP Clinical Trial Award mechanism supports the rapid execution of clinical trials with the potential to have a significant impact on the treatment or management of psychological… Read more »
The Toxic Exposures Research Program (TERP) released program announcements for the following funding opportunities: Clinical Trial Award The TERP Clinical Trial Award (CTA) mechanism supports the advancement, execution, and analysis of clinical trials with the potential to have a significant impact on the prevention, treatment or management of symptoms, diseases, or conditions associated with or… Read more »
The Toxic Exposures Research Program (TERP) released program announcements for the following funding opportunities: Clinical Trial Award The TERP Clinical Trial Award (CTA) mechanism supports the advancement, execution, and analysis of clinical trials with the potential to have a significant impact on the prevention, treatment or management of symptoms, diseases, or conditions associated with or… Read more »
The Prostate Cancer Research Program (PCRP) released program announcements for the following funding opportunities: Data Science Award The FY26 PCRP Data Science Award (DSA) supports research that develops or uses quantitative and analytical approaches, processes and/or systems to obtain knowledge and insight from large and/or complex sets of prostate cancer data. If successful, the studies… Read more »
The Prostate Cancer Research Program (PCRP) released program announcements for the following funding opportunities: Data Science Award The FY26 PCRP Data Science Award (DSA) supports research that develops or uses quantitative and analytical approaches, processes and/or systems to obtain knowledge and insight from large and/or complex sets of prostate cancer data. If successful, the studies… Read more »
The Military Burn Research Program (MBRP) released program announcements for the following funding opportunities: Discovery Award The FY26 MBRP Discovery Award is intended to support innovative, untested, non-incremental, groundbreaking research that provides new insights, paradigms, technologies, or applications in combat-relevant burn care. The proposed project may be exploratory, hypothesis-driven, or hypothesis-generating research, but must be… Read more »
The Military Burn Research Program (MBRP) released program announcements for the following funding opportunities: Discovery Award The FY26 MBRP Discovery Award is intended to support innovative, untested, non-incremental, groundbreaking research that provides new insights, paradigms, technologies, or applications in combat-relevant burn care. The proposed project may be exploratory, hypothesis-driven, or hypothesis-generating research, but must be… Read more »
The Melanoma Research Program (MRP) released program announcements for the following funding opportunities: Melanoma Academy Scholar Award The intent of the FY26 MASA is to solicit applications for Scholars to join the MA. This award mechanism enables the Scholar to pursue a melanoma project, with the guidance of a Career Guide, that may be basic,… Read more »
The Melanoma Research Program (MRP) released program announcements for the following funding opportunities: Melanoma Academy Scholar Award The intent of the FY26 MASA is to solicit applications for Scholars to join the MA. This award mechanism enables the Scholar to pursue a melanoma project, with the guidance of a Career Guide, that may be basic,… Read more »
The Melanoma Research Program (MRP) released program announcements for the following funding opportunities: Focused Program Award – Rare Melanomas The FY26 MRP FPA-RM supports a multidisciplinary research program of at least two, but not more than three, distinct but complementary projects addressing an overarching question relevant to rare melanomas (see Figure 1). Applications for the… Read more »
The Melanoma Research Program (MRP) released program announcements for the following funding opportunities: Focused Program Award – Rare Melanomas The FY26 MRP FPA-RM supports a multidisciplinary research program of at least two, but not more than three, distinct but complementary projects addressing an overarching question relevant to rare melanomas (see Figure 1). Applications for the… Read more »
The Epilepsy Research Program (ERP) released program announcements for the following funding opportunities: Leveraging Research Award The intent of the Leveraging Research Award is to support basic, translational, and/or clinical research that repurposes or expands existing research resources to accelerate the understanding of PTE and associated comorbidities. Virtual Post-Traumatic Epilepsy Research Center (ViP-TERC) – Faulty… Read more »
The Epilepsy Research Program (ERP) released program announcements for the following funding opportunities: Leveraging Research Award The intent of the Leveraging Research Award is to support basic, translational, and/or clinical research that repurposes or expands existing research resources to accelerate the understanding of PTE and associated comorbidities. Virtual Post-Traumatic Epilepsy Research Center (ViP-TERC) – Faulty… Read more »
The Autism Research Program (ARP) released program announcements for the following funding opportunities: – Career Development Award The Career Development Award (CDA) supports early-career, independent investigators and/or the transition of established investigators from other research fields to conduct innovative, highimpact ideas or early-phase, proof-of-principle clinical trials with the potential to have a major impact on autism. – Clinical… Read more »
The Autism Research Program (ARP) released program announcements for the following funding opportunities: – Career Development Award The Career Development Award (CDA) supports early-career, independent investigators and/or the transition of established investigators from other research fields to conduct innovative, highimpact ideas or early-phase, proof-of-principle clinical trials with the potential to have a major impact on autism. – Clinical… Read more »
The VRP MCRA supports patient-oriented vision injury research conducted by highly motivated military or civilian clinicians in training. The MCRA may be used to support a standalone study of high impact to vision injury care or the generation of clinical research data in preparation for a more expansive study. The MCRA can only be used… Read more »
The VRP MCRA supports patient-oriented vision injury research conducted by highly motivated military or civilian clinicians in training. The MCRA may be used to support a standalone study of high impact to vision injury care or the generation of clinical research data in preparation for a more expansive study. The MCRA can only be used… Read more »
Clinical Trial Award The VRP CTA supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of service-connected eye injury and visual dysfunction. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs, biologics or medical devices), clinical guidance and/or emerging approaches… Read more »
Clinical Trial Award The VRP CTA supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of service-connected eye injury and visual dysfunction. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs, biologics or medical devices), clinical guidance and/or emerging approaches… Read more »
Idea Development Award The intent of the FY26 TBDRP IDA is to support conceptually innovative research that could lead to impactful discoveries or significant advancements that will accelerate progress toward reducing the burden of Lyme disease and/or other tick-borne diseases and conditions, and improving patient care and/or quality of life. Research supported by an IDA… Read more »
Idea Development Award The intent of the FY26 TBDRP IDA is to support conceptually innovative research that could lead to impactful discoveries or significant advancements that will accelerate progress toward reducing the burden of Lyme disease and/or other tick-borne diseases and conditions, and improving patient care and/or quality of life. Research supported by an IDA… Read more »
Impact Award The FY26 PRMRP Impact Award supports applied research, defined as use-inspired and practice-oriented science that brings together outcomes from basic research, and insights from the real-world environment, to foster clinical applicability. The Impact Award intends to translate the fundamental understanding of underlying mechanisms toward clinical applications that have the potential for major near-term… Read more »
Impact Award The FY26 PRMRP Impact Award supports applied research, defined as use-inspired and practice-oriented science that brings together outcomes from basic research, and insights from the real-world environment, to foster clinical applicability. The Impact Award intends to translate the fundamental understanding of underlying mechanisms toward clinical applications that have the potential for major near-term… Read more »
Discovery Award The FY26 PRMRP Discovery Award intends to support innovative, untested, non-incremental, high-risk/potentially high-reward research that will provide new insights, paradigms, technologies or applications. The proposed project may be exploratory, hypothesis-driven, or hypothesis-generating research, but must be novel and must be based on a strong scientific rationale and a well-developed study design and plan… Read more »
Discovery Award The FY26 PRMRP Discovery Award intends to support innovative, untested, non-incremental, high-risk/potentially high-reward research that will provide new insights, paradigms, technologies or applications. The proposed project may be exploratory, hypothesis-driven, or hypothesis-generating research, but must be novel and must be based on a strong scientific rationale and a well-developed study design and plan… Read more »
The PRMRP Clinical Trial Award (CTA) mechanism supports the rapid execution and analysis of clinical trials with the potential to have a significant impact on the treatment or management of a disease or condition addressed in one of the congressionally directed FY26 PRMRP Topic Areas and FY26 PRMRP Strategic Goals. Clinical trials may be designed… Read more »
Clinical Trial Award The PRMRP Clinical Trial Award (CTA) mechanism supports the rapid execution and analysis of clinical trials with the potential to have a significant impact on the treatment or management of a disease or condition addressed in one of the congressionally directed FY26 PRMRP Topic Areas and FY26 PRMRP Strategic Goals. Clinical trials… Read more »
The FY26 LCRP Patient-Centered Outcomes and Survivorship Award (PCOSA) supports highrisk, high-reward research studies that span the spectrum of survivorship, health outcomes and comparative effectiveness research, including quality of life, symptom and side effect management, resilience, and co-morbid conditions. The overall intent of the FY26 LCRP Patient-Centered Outcomes and Survivorship Award is to promote evidence-based… Read more »
The FY26 LCRP Patient-Centered Outcomes and Survivorship Award (PCOSA) supports highrisk, high-reward research studies that span the spectrum of survivorship, health outcomes and comparative effectiveness research, including quality of life, symptom and side effect management, resilience, and co-morbid conditions. The overall intent of the FY26 LCRP Patient-Centered Outcomes and Survivorship Award is to promote evidence-based… Read more »
Idea Development Award The FY26 LCRP Idea Development Award (IDA) mechanism promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate… Read more »
Idea Development Award The FY26 LCRP Idea Development Award (IDA) mechanism promotes new ideas that are still in the early stages of development and have the potential to yield impactful data and new avenues of investigation. This award supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate… Read more »
Focused Research Award The FRA supports promising basic through translational research that accelerates drug discovery and therapeutic development for hearing restoration after military-relevant auditory system injury. The FRA may be used to support preclinical studies and/or clinical research. However, the FRA may not be used to conduct clinical trials. Tinnitus or vestibular-related research is excluded…. Read more »
Focused Research Award The FRA supports promising basic through translational research that accelerates drug discovery and therapeutic development for hearing restoration after military-relevant auditory system injury. The FRA may be used to support preclinical studies and/or clinical research. However, the FRA may not be used to conduct clinical trials. Tinnitus or vestibular-related research is excluded…. Read more »
Clinical Trial Award The FY26 PRCRP Clinical Trial Award (CTA) mechanism supports the rapid execution and analysis of clinical trials with the potential to have a significant impact on the treatment or management of cancer within at least one of the FY26 PRCRP Topic Areas. Investigators may design a clinical trial to evaluate promising new… Read more »
Clinical Trial Award The FY26 PRCRP Clinical Trial Award (CTA) mechanism supports the rapid execution and analysis of clinical trials with the potential to have a significant impact on the treatment or management of cancer within at least one of the FY26 PRCRP Topic Areas. Investigators may design a clinical trial to evaluate promising new… Read more »
Clinical Translational Research Award The CTRA supports studies that will move promising, well-founded preclinical and/or clinical research findings closer to clinical application, including diagnosis, prognosis or treatment of TSC. Exploration-Hypothesis Development Award The Exploration-Hypothesis Development Award (EHDA) supports the initial exploration of innovative, high-risk, high-gain and potentially groundbreaking concepts in the TSC research field. The… Read more »
Clinical Translational Research Award The CTRA supports studies that will move promising, well-founded preclinical and/or clinical research findings closer to clinical application, including diagnosis, prognosis or treatment of TSC. Exploration-Hypothesis Development Award The Exploration-Hypothesis Development Award (EHDA) supports the initial exploration of innovative, high-risk, high-gain and potentially groundbreaking concepts in the TSC research field. The… Read more »
Clinical Trial Award The MSRP Clinical Trial Award mechanism supports the rapid execution and analysis of clinical trials with the potential to have a significant impact on the treatment or management of multiple sclerosis (MS). Clinical trials may evaluate promising new products, pharmacologic agents (drugs, biologics, or medical devices), clinical guidance, and/or emerging approaches and… Read more »
Clinical Trial Award The MSRP Clinical Trial Award mechanism supports the rapid execution and analysis of clinical trials with the potential to have a significant impact on the treatment or management of multiple sclerosis (MS). Clinical trials may evaluate promising new products, pharmacologic agents (drugs, biologics, or medical devices), clinical guidance, and/or emerging approaches and… Read more »
Idea Award The LRP IA supports innovative, high-risk/high-reward research that could ultimately lead to a critical discovery or major advancement relevant to lupus. This award mechanism supports studies that have the potential to reveal entirely new avenues for investigation. The application must describe how the new idea will enhance the existing knowledge of lupus or… Read more »
Idea Award The LRP IA supports innovative, high-risk/high-reward research that could ultimately lead to a critical discovery or major advancement relevant to lupus. This award mechanism supports studies that have the potential to reveal entirely new avenues for investigation. The application must describe how the new idea will enhance the existing knowledge of lupus or… Read more »
Clinical Translation Research Award The SCIRP CTRA is intended to support high-impact, new or emerging clinical research that requires additional preliminary studies, such as feasibility, pilot or optimization, to prepare for future larger-scale clinical trials or implementation. This funding mechanism has two objectives: • Advance Clinical Translation: To accelerate the translation of current and emerging… Read more »
Clinical Translation Research Award The SCIRP CTRA is intended to support high-impact, new or emerging clinical research that requires additional preliminary studies, such as feasibility, pilot or optimization, to prepare for future larger-scale clinical trials or implementation. This funding mechanism has two objectives: • Advance Clinical Translation: To accelerate the translation of current and emerging… Read more »
Idea Development Award The PCARP Idea Development Award supports the development of innovative, high-risk/highreward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with pancreatic cancer. Innovative ideas with the potential to yield impactful data and new avenues of investigation are the focus of this… Read more »
Idea Development Award The PCARP Idea Development Award supports the development of innovative, high-risk/highreward research that could lead to critical discoveries or major advancements that will accelerate progress in improving outcomes for individuals with pancreatic cancer. Innovative ideas with the potential to yield impactful data and new avenues of investigation are the focus of this… Read more »
The PCARP Focused Pilot Award supports the exploration and development of impactful and innovative concepts under a patient-centered focus area of pancreatic cancer research that could ultimately lead to major advancements that will have a profound effect on patients’ overall quality of life. The research this award supports should strive to produce robust preliminary data… Read more »
The PCARP Focused Pilot Award supports the exploration and development of impactful and innovative concepts under a patient-centered focus area of pancreatic cancer research that could ultimately lead to major advancements that will have a profound effect on patients’ overall quality of life. The research this award supports should strive to produce robust preliminary data… Read more »
Investigator-Initiated Research Award The OCRP Investigator-Initiated Research Award (IIRA) is intended to support high-impact research that addresses a critical need and has the potential to make an important contribution to ovarian cancer or patient/survivor care. Research projects may focus on any phase of research, from basic laboratory research through translational research, excluding clinical trials. The… Read more »
Investigator-Initiated Research Award The OCRP Investigator-Initiated Research Award (IIRA) is intended to support high-impact research that addresses a critical need and has the potential to make an important contribution to ovarian cancer or patient/survivor care. Research projects may focus on any phase of research, from basic laboratory research through translational research, excluding clinical trials. The… Read more »
Clinical Trial Award The OCRP Clinical Trial Award mechanism supports the rapid execution and analysis of clinical trials with the potential to have a significant impact on the treatment or management of ovarian cancer. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs, biologics or medical devices), clinical guidance, and/or emerging… Read more »
Clinical Trial Award The OCRP Clinical Trial Award mechanism supports the rapid execution and analysis of clinical trials with the potential to have a significant impact on the treatment or management of ovarian cancer. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs, biologics or medical devices), clinical guidance, and/or emerging… Read more »
Breakthrough Award Level 3 The intent of the FY26 BCRP Breakthrough Award is to support promising research with high potential to lead to or make breakthroughs in breast cancer. This funding level supports advanced translational studies. Where relevant, the application must demonstrate proof of the availability of, and access to, necessary data, samples, cohort(s), and/or… Read more »
Breakthrough Award Level 3 The intent of the FY26 BCRP Breakthrough Award is to support promising research with high potential to lead to or make breakthroughs in breast cancer. This funding level supports advanced translational studies. Where relevant, the application must demonstrate proof of the availability of, and access to, necessary data, samples, cohort(s), and/or… Read more »
Breakthrough Award Levels 1 and 2 Proposed research must have the potential for a major impact and accelerate progress toward ending breast cancer. The near-term and/or long-term impact must move beyond a minor advancement and have the potential to lead to a fundamentally new strategy or approach to preventing or ending breast cancer that is… Read more »
Breakthrough Award Levels 1 and 2 Proposed research must have the potential for a major impact and accelerate progress toward ending breast cancer. The near-term and/or long-term impact must move beyond a minor advancement and have the potential to lead to a fundamentally new strategy or approach to preventing or ending breast cancer that is… Read more »
Clinical Research Award The FY26 ATRP Clinical Research Award (CRA) is intended to support clinical research that evaluates disease-specific factors and interventions. Research supported by this mechanism is intended to generate clinically useful evidence with potential to optimize patient outcomes and inform clinical care or policy. Research addressing any and all types of arthritis is… Read more »
Clinical Research Award The FY26 ATRP Clinical Research Award (CRA) is intended to support clinical research that evaluates disease-specific factors and interventions. Research supported by this mechanism is intended to generate clinically useful evidence with potential to optimize patient outcomes and inform clinical care or policy. Research addressing any and all types of arthritis is… Read more »
Clinical Outcomes and Biomarkers Award The FY26 ALSRP COBA supports the development and/or validation of clinical outcomes and biomarkers to enrich clinical trials in ALS. Projects can be relevant to a specific therapy, a class of therapeutics, or to a specific ALS subtype (such as a particular genetic mutation) and do not have to broadly… Read more »
Clinical Outcomes and Biomarkers Award The FY26 ALSRP COBA supports the development and/or validation of clinical outcomes and biomarkers to enrich clinical trials in ALS. Projects can be relevant to a specific therapy, a class of therapeutics, or to a specific ALS subtype (such as a particular genetic mutation) and do not have to broadly… Read more »
Transforming Care Award The FY26 TrCA intends to support well-designed non-incremental clinical research/trials in dementia care that provide significant impact and solutions for the AD/ADRD field, Community, and military health. Funded research will support the evaluation of interventions, innovations, and solutions in critical areas in dementia care. Applications may address knowledge gaps, interventions, strategies, technologies… Read more »
Transforming Care Award The FY26 TrCA intends to support well-designed non-incremental clinical research/trials in dementia care that provide significant impact and solutions for the AD/ADRD field, Community, and military health. Funded research will support the evaluation of interventions, innovations, and solutions in critical areas in dementia care. Applications may address knowledge gaps, interventions, strategies, technologies… Read more »
Pharmacotherapies for Alcohol and Substance Use Disorder Alliance The PASA’s goal is to fund studies that explore integrated approaches to address ASUD, especially comorbid ASUD with PTSD and other mental health conditions, and reduce the number of opioid and other substance use-related deaths through multidisciplinary, team-based research efforts that translate knowledge into enhanced clinical pharmacological… Read more »
Pharmacotherapies for Alcohol and Substance Use Disorder Alliance The PASA’s goal is to fund studies that explore integrated approaches to address ASUD, especially comorbid ASUD with PTSD and other mental health conditions, and reduce the number of opioid and other substance use-related deaths through multidisciplinary, team-based research efforts that translate knowledge into enhanced clinical pharmacological… Read more »
The Mobilizing Insights in Defence and Security (MINDS) program is pleased to announce the launch of the Collaborative Networks competition for fiscal year 2025-2026. Applications can be submitted until January 19, 2026 23:59 (PST). Applications received passed this deadline will not be accepted. MINDS Collaborative Networks involve multi-disciplinary teams of experts from across Canada and abroad. Networks increase and diversify research on defence and security issues in Canada, with the aim… Read more »
The USAMRDC’s mission is to provide solutions to medical problems of importance to the American Service Member at home and abroad, as well as to the general public at large. The scope of this effort and the priorities attached to specific projects are influenced by changes in military and civilian medical science and technology (S&T),… Read more »
The USAMRDC’s mission is to provide solutions to medical problems of importance to the American Service Member at home and abroad, as well as to the general public at large. The scope of this effort and the priorities attached to specific projects are influenced by changes in military and civilian medical science and technology (S&T),… Read more »
The Autism Research Program (ARP) released program announcement for the following funding opportunity: Discovery Award To view the program announcements and submit a pre-application visit: https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=577102 The FY24 ARP Discovery Award supports innovative, non-incremental, high-risk/potentially high-reward research that will provide new insights, paradigms, technologies, or applications in autism research. Studies supported by this award are… Read more »
The Autism Research Program (ARP) released program announcement for the following funding opportunity: Discovery Award To view the program announcements and submit a pre-application visit: https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=577102 The FY24 ARP Discovery Award supports innovative, non-incremental, high-risk/potentially high-reward research that will provide new insights, paradigms, technologies, or applications in autism research. Studies supported by this award are… Read more »
The Joint Warfighter Medical Research Program (JWMRP) was established in Fiscal Year 2012 to specifically support the logical continuation of Department of Defense (DOD) funded medical research and development projects, making it unique among CDMRP programs. Per Congressional language, JWMRP funds may not be used for new projects or basic research, but instead they are intended to… Read more »
The Joint Warfighter Medical Research Program (JWMRP) was established in Fiscal Year 2012 to specifically support the logical continuation of Department of Defense (DOD) funded medical research and development projects, making it unique among CDMRP programs. Per Congressional language, JWMRP funds may not be used for new projects or basic research, but instead they are intended to… Read more »
